CONTACT US
A Korea Health Industry Development Institute feature highlighted BiX's multimodal AI platform for earlier abdominal cancer detection, its clinical collaboration model, and its path toward PACS-integrated commercialization.
Read full story
BiX has been selected for the 12th cohort of Shinhan Future's Lab, joining 46 startups chosen from a record pool of 800 applicants.
Read full story
BiX was selected for the Korean Ministry of SMEs and Startups' TIPS program to accelerate research and commercialization of DeepScout, its abdominal multi-organ diagnostic AI platform.
Read full story
BiX secured KRW 300 million in Pre-A funding from Shinhan Venture Investment in November 2025, strengthening the company's resources for medical AI research and clinical translation.
Read full story
BiX received the Top Excellence Award in the faculty startup category at the 2025 Ewha Life-Tech Startup Competition, recognizing the clinical and business potential of its medical AI technology.
Read full story
BiX raised a total of KRW 100 million in seed funding from Star Ventures and the Star Innovation private investment association in March 2025.
Read full story
Seoul Shinmun covered BiX's development of DeepScout and its use of quantitative CT and clinical information to support earlier multi-cancer diagnosis.
Read full story
Aju Business Daily reported on BiX's planned launch of DeepScout, highlighting its integrated analysis of CT and clinical information for earlier multi-cancer detection.
Read full story
BiX introduced DeepScout, a multimodal AI solution designed to identify pre-cancer signals by combining medical imaging and clinical information across abdominal organs.
Read full story